A phase 1 trial of Glumetinib in patients with advanced solid tumors
Latest Information Update: 24 Aug 2022
At a glance
- Drugs Gumarontinib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Haihe Biopharma
Most Recent Events
- 24 Aug 2022 New trial record